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Abstract Occasional clinical reports have suggested a link
betweenmigraineandrestlesslegssyndrome.Weundertooka
systematic review of the evidence, which supports this asso-
ciation,and considerpossiblesharedpathogenicmechanisms
and the implications for current clinical practice.
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Introduction
Comorbidity may be deﬁned as the association of two
diseases in individuals at a frequency greater than that
expected statistically by chance. Migraine may be com-
plicated by the presence of a number of comorbidities
(Table 1)[ 1, 2]. These comorbid conditions may augment
the perceived severity of migrainous symptoms and/or pose
additional challenges for effective patient management. It
is therefore essential that any disease co-existing with
migraine is identiﬁed and managed appropriately.
Restless legs syndrome (RLS), also known as Ekbom’s
syndrome [3], is a condition characterised by uncomfort-
able and sometimes painful sensory disturbances in the
lower limbs producing an irresistible urge to move in order
to relieve the sensation, particularly at rest and at night.
RLS was not until recent times considered a possible
migraine comorbidity [1]. Indeed, two recently published
texts devoted to RLS reﬂect the uncertainty: Chaudhuri
et al. [4] stated that RLS is seen in increased frequency in
migraine cases, whereas Hening et al. [5] did not even
mention migraine in their extensive (and contemporane-
ous) monograph.
Since RLS is a potentially treatable condition [4, 5], it is
important to clarify whether it is comorbid with migraine.
The availability of validated criteria for the diagnosis of
RLS, the IRLSSG criteria [6], might facilitate study of this
question. We therefore undertook a review of the available
evidence which addresses this issue, and considered pos-
sible mechanisms of pathogenic overlap between migraine
and RLS.
Method
The medical databases Ovid, PubMed and NHS Evidence
were searched by combining the key terms, migraine or
migrain$ with restless legs syndrome. Electronic searches
were supplemented by hand searching the bibliographies of
relevant articles. Both authors read the title and abstract of
all studies identiﬁed by the electronic searches, and agreed
on eligibility of the studies identiﬁed, the full text of which
was read and critically appraised.
Results
From the articles retrieved (Table 2), we identiﬁed eight
studies deemed eligible for inclusion [7–14].
No population-based study of the coincidence of
migraine and RLS was identiﬁed, but several studies of
clinical samples have been reported. Young et al. [7]
screened 50 primary headache patients with intractable
headache admitted to an outpatient infusion centre using
the IRLSSG criteria. They reported that 34% of their
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that the RLS prevalence rate in the general population has
traditionally been stated to be between 1 and 10% [15, 16],
although this may be lower in Asian populations [10].
Clearly, this was a small study sample and there was no
control group, but the ﬁndings have been largely conﬁrmed
in subsequent studies.
Rhode et al. performed a case control study on 411
patients with migraine with 411 age- and sex-matched con-
trol subjects and found that the former had a statistically
signiﬁcant higher lifetime prevalence of RLS than the con-
trol group (17.3 vs. 5.6%, p\0.001) [8]. It was also noted
thatmigrainepatientswithRLStendedtobeolderthanthose
without RLS, in keeping with the epidemiological ﬁnding
that RLS incidence typically increases with age.
In an observational study, d’Onofrio et al. [9] conducted
interviews and neurological examinations in 200 patients
affected by primary headaches and in 120 age- and sex-
matched controls. They reported an increased RLS preva-
lence in headache patients compared to control subjects
(22.4 vs. 8.3%, p = 0.002), with a preponderance in
patients who suffered from migraine without aura. Sleep
disturbances were more frequent in headache patients with
RLS (50.0 vs. 32.7%, p\0.001).
Chen et al. [10] compared the prevalence of RLS
between different primary headache groups. Headache
diagnosis was based partly on physician interview and
partly on patient-completed questionnaire, and RLS diag-
nosis was based on IRLSSG questionnaire conﬁrmed by
physician telephone interview. Of the 1,041 headache
patients recruited, 772 had migraine, 218 tension-type
headaches (TTH), and 51 cluster headaches (CH). There
was no control group. The study found that RLS was more
common in migraine patients (11.4%) than in TTH (4.6%)
and CH (2.0%) (p = 0.002). The lower frequency of RLS
in this population compared to the previously mentioned
studies [7–9] suggested that an ethnic factor may contribute
to RLS prevalence. Frequency of RLS increased with
increasing number of migrainous symptoms (linear by
linear association, p\0.001).
Migraine patients with RLS had worse scores in six of
the seven components of the Pittsburgh Sleep Quality
Index (PSQI), a questionnaire used to assess sleep quality
in the past month, in which total scores range from 0 to 21
with a score greater than 5 indicating poor sleep quality.
Patients with migraine and RLS were found to be more
likely to have a PSQI score greater than 5 compared to the
patients with migraine alone (92.0 vs. 78.1%, p = 0.002).
The study thus indicated that RLS might have a negative
impact on sleep quality in migraine patients.
Limitations of these studies include the use of selected
populations, use of patient questionnaires which may be
subject to recall bias, and the adoption of cross sectional
study designs which give only point, rather than lifetime,
prevalence.
Pathogenesis
Despite the potential limitations of these four clinical
studies, they have consistently found that RLS is more
common in migraine patients than in comparator groups. If
migraine and RLS are comorbid, rather than simply coin-
cident, are there shared aetiological factors and/or patho-
genic mechanisms which might explain the association? A
number of possible explanations have been offered for the
association of RLS and primary headache, three of which
(not mutually exclusive) have attracted most attention:
dopaminergic dysfunction and dysfunctional brain iron
metabolism; genetic linkage; and sleep disturbance.
Dopaminergic dysfunction and dysfunctional brain iron
metabolism
It has been postulated that RLS may be caused by dys-
function in central dopaminergic pathways. The strongest
argument in favour of this is the rapid and dramatic
improvement in RLS symptoms with dopamine agonist
drugs which are now licensed for the treatment of RLS
Table 1 Recognised comorbidities of migraine [1, 2]
Stroke
Subclinical vascular brain lesions
Coronary artery disease
Patent foramen ovale
Affective disorders: depression, anxiety
Epilepsy
Fibromyalgia
Possible comorbid conditions
Irritable bowel syndrome
Coeliac disease
Chronic fatigue syndrome
Raynaud’s phenomenon
Asthma
Narcolepsy
Sleep deprivation
Table 2 Articles retrieved by search strategy
Database Results obtained
Migraine or migrain$
and restless legs syndrome
Ovid (Medline) 12
PubMed 23
NHS evidence 50
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123[17]. Animal models have shown that lesions to the A11
dopaminergic nucleus of the dorsal-posterior hypothala-
mus, the only nucleus providing dopaminergic stimulation
to the spinal cord, produces a RLS-like phenotype [18].
Dopamine has also been implicated in migraine patho-
genesis: there is evidence for dopamine receptor hyper-
sensitivity in migraine patients [19]. Administration of low
doses of dopamine agonists can trigger attacks of pre-
monitory symptoms in migraineurs, including nausea,
yawning and food craving. Conversely, dopamine antago-
nists may be of use in migraine treatment. Of note, when a
trial of the dopamine antagonist droperidol was performed
in acute migraine, a commonly reported side-effect was
‘‘acute drug-induced akathisia’’ [20], which might possibly
have been RLS [21] since the two conditions may be dif-
ﬁcult to differentiate clinically. Young et al. [7] also found
that headache patients with RLS were at a greatly increased
risk of developing drug-induced akathisia when treated
with intravenous dopamine receptor blocking agents.
Cologno et al. [11] carried out a case control study on
164 patients with primary headache disorders screening
each participant for the presence of RLS and premonitory
migraine dopaminergic symptoms (yawning, nausea,
somnolence or food craving). Concordant with previous
studies, an increased incidence of RLS was found in
migraineurs (25.6%). Intriguingly, those with co-existing
migraine and RLS reported a higher prevalence of dopa-
minergic symptoms accompanying their migraine attacks
than those without RLS (47.6 vs. 13.1%, p\0.001),
adding to the argument that a dopaminergic imbalance
could be the pathogenic connection between migraine and
RLS.
Iron dysmetabolism is well recognised in RLS, some
cases being secondary to iron deﬁciency, and iron therapy
being one approach to treatment of RLS [22]. There may
be a link between brain iron and dopamine systems. Iron
accumulation has also been documented in the brains of
migraine patients [23].
Genetic linkage
Individually, RLS and migraine seem to exhibit a poly-
genic inheritance pattern, both occurring with increased
frequency in those with positive family histories. Cur-
rently, at least seven genetic loci have been linked to RLS
[17, 24]. In addition, occasional pedigrees in which RLS
and migraine appear to co-segregate over several genera-
tions have been presented [12, 13].
Sabayan et al. [14] suggested that it was credible to
assume that migraine and RLS may have a joint origin,
based in part on a common genetic linkage mapped to
chromosome 14q21. This was described in an Italian
family with idiopathic autosomal dominant RLS (OMIM
%608831) [24]; one patient in the pedigree (III.17) had
both RLS and migraine [25]. Soragna et al. [24] described a
susceptibility locus for migraine without aura (OMIM
%607501), also at 14q21, but there was no mention of RLS
in affected individuals in this Italian family [26].
Sleep disturbance
Sleep disorders are observed in a disproportionate number
of patients with primary headache disorders [27]. Epide-
miological studies indicate that sleep deprivation is one of
the most common precipitating factors for migraine attacks
[28, 29]. Improving sleep hygiene is often a component of
headache management strategies, which alone may resolve
or greatly improve headache complaints in some cases
[30].
Given that RLS is, by deﬁnition, worse at nighttime, it is
not surprising that the vast majority of RLS patients have
sleep complaints [31]. Might the sleep disturbance caused
by RLS exacerbate migraine and so explain the link
between the two conditions? As previously mentioned, two
of the epidemiological studies of migraine and RLS found
sleep disturbance to be more evident in headache patients
with RLS [9, 10].
Clinical trials have shown that treating RLS with
dopamine agonists can enhance sleep quality [32]. How-
ever, there are currently no data which address the issue of
whether treating RLS can improve the sleep of migraine
patients and thus beneﬁt migraine control, albeit that
dopamine agonists may provoke premonitory migraine
symptoms. Future studies might include a randomised
control trial assessing this aspect of migraine management.
Discussion
Studies in selected patient groups strongly suggest that
RLS is more common in migraine patients than in control
populations. However, a population-based study, perhaps
the most deﬁnitive way to establish concurrence, has yet to
be reported. It should be noted that certain conditions
found to be comorbid with migraine in clinic-based studies
were not conﬁrmed as such in population-based studies
(e.g. hypertension) [2].
There are a number of plausible hypotheses, which might
explain a link between migraine and RLS. Of these, some
have favoured dopaminergic imbalance. However, the
opposing effects of dopaminergic agonists (improve RLS,
provoke migraine premonitory symptoms) and antagonists
(improve migraine, provoke drug-induced akathisia) in the
two conditions would seem to negate any simplistic expla-
nation at the level of neurotransmitter release or receptor
sensitivity. Central mechanisms rendering the brain more
J Headache Pain (2011) 12:405–409 407
123sensitive to sensory stimuli with impaired habituation might
be invoked, but precise mechanisms remain elusive. Hence,
other explanations of the RLS-migraine link remain viable,
of which sleep disturbance, as a consequence of RLS and as
a trigger for migraine, remains an attractive possibility.
Whilst knowledge remains incomplete, what should be
the pragmatic response to these data at the clinical inter-
face? For example, should migraine patients attending the
headache clinic be screened for RLS? Current (2010)
guidelines from the British Association for the Study of
Headache (www.bash.org.uk) do not mention RLS, far less
advocate screening for it. It would certainly be difﬁcult at
this point in time to make a robust case for RLS screening
in all headache patients, far less for measuring iron indices
in all migraine patients. Nevertheless, it may be deemed
good practice for clinicians to be vigilant for RLS symp-
toms in migraine patients, particularly in those with com-
plaints of sleep disturbance or excessive daytime
somnolence. Such screening for RLS might be performed
with a single question [33]. However, even if a diagnosis of
RLS is made, there is currently no evidence that speciﬁc
RLS treatment will impact on migraine symptoms, indeed
these drugs may cause adverse effects. Nonetheless, the
possibility that improved sleep quality following treatment
of RLS might be associated with improvement in migraine
has some face validity.
Clearly more studies are required at both the basic and
clinical level in this area to address the many outstanding
questions. Trials in which both migraine and RLS symp-
toms are evaluated concurrently may help to inform clin-
ical practice.
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